Our previous studies showed that the methylation of SEPT9 is associated with the TNM stage, total tumor volume, and mismatch repair deficient status (Sun et al., 2019), suggesting that mSEPT9 in peripheral blood may be related with the pathological stage and the prognosis of patients. The gene discussed is SEPTIN9; the disease is neoplasm.